• Skip to main content

Duke ALS Clinic

Duke ALS Clinic multi-disciplinary team identifies specific ALS symptoms and problems and provides a wide range of options for dealing with them.

  • Our Clinic
    • History and Evolution of the Duke ALS Clinic
    • Our Team
    • Telemedicine
    • Contact Us
  • Our Research
    • Clenbuterol module
    • Microbiome module
    • ALS Reversals module
    • Other Studies
  • Sponsors
  • How You Can Help

Search Duke ALS Clinic

11 events found.

Events Search and Views Navigation

Event Views Navigation

  • List
  • Month
  • Day

Events

Today
  • January 2022

  • Mon 17

    Dr. Bedlack’s views on a new Edaravone study were quoted on Medscape and ALZForum

    January 17, 2022

    You can read it here: https://www.medscape.com/viewarticle/966717#vp_1 https://www.alzforum.org/papers/safety-and-effectiveness-long-term-intravenous-administration-edaravone-treatment-patients#comment-43841

  • Sun 30

    Our team was part of a new publication which described the results of a clinical trial of NP001.

    January 30, 2022

    You can read it here: https://pubmed.ncbi.nlm.nih.gov/35098554/https://pubmed.ncbi.nlm.nih.gov/35098554/

  • February 2022

  • Tue 1

    “Fashionably Fighting ALS.”

    February 1, 2022

    Today we celebrated the Lunar New Year, which is The Year of the Tiger

  • Thu 10

    Mansour and Bedlack interviewed about the interaction between ALS and sleep disorders on Sleep is a Skill podcast.

    February 10, 2022

    You can listen here:

  • Wed 16

    Dr. Bedlack was part of a panel of experts, convened by Icon to review ways to optimize Diversity and Inclusion in clinical research.

    February 16, 2022

    You can view the discussion here:  https://app.wipster.io/Review/CefFOgB-giARQiOb3GKXYFaPvsd6DXu8NaipaPFfYo-gz3aEMA

  • Mon 28

    Our ALSUntangled team published its latest review, this one on Butyrates.

    February 28, 2022

    You can find it here:  https://www.tandfonline.com/doi/abs/10.1080/21678421.2022.2045323?journalCode=iafd20

  • March 2022

  • Tue 1

    Dr. Bedlack joined a large group of clinicians and people living with ALS in an Action Summit convened by IAMALS. The purpose was to discuss ways we can all work together to streamline and improve ALS Clinical Research.

    March 1, 2022 - March 2, 2022

    You can read more about this here:  https://iamals.org/action/als-action-summit/

  • Thu 3

    In partnership with our colleagues in the CReATe Consortium, we posted a new ALSUntangled podcast on Ketogenic Diets.

    March 3, 2022

    Listen to "ALS Untangled Series: Ep. 45 - Ketogenic Diets" on Spreaker. You can listen to this and many other ALSUntangled podcasts here:

  • Thu 17

    “May your troubles be less and your blessings be more, And nothing but happiness come through your door.”

    March 17, 2022
  • Mon 28

    Bedlack quoted in support of AMX0035 in new Biospace article. 

    March 28, 2022

    From left: Amylyx Co-founders and Co-CEOs Justin Klee and Josh Cohen/Courtesy Amylyx . The FDA’s Peripheral and Central Nervous System Drugs Advisory Committee will face its first big test since […]

  • Wed 30

    Dr. Bedlack will testify to the FDA in support of AMX0035

    March 30, 2022
  • Today
  • Next Events
  • Google Calendar
  • iCalendar
  • Outlook 365
  • Outlook Live
  • Export .ics file
  • Export Outlook .ics file

© 2026 Duke ALS Clinic · All Rights Reserved · Website by Code the Dream